Results 241 to 250 of about 52,797 (313)

Digital payments of health workers within vaccination campaigns: a mixed-methods study in Chad. [PDF]

open access: yesBMJ Glob Health
Bedingar EKN   +10 more
europepmc   +1 more source

Crisis micro‐learning: A framework for understanding the micro‐flow of policy learning and Australia's COVID‐19 response

open access: yesAustralian Journal of Public Administration, EarlyView.
Abstract COVID‐19 has intensified interest in crisis policy learning, yet the micro‐level interactions among political, bureaucratic, and expert actors remain underexplored. We conceptualise an ideal‐type framework for the micro‐flow of crisis learning, an ordinarily epistemic and context‐specific process of individual‐level interactions, where lessons
Neil Mortimer, Nicholas Bromfield
wiley   +1 more source

Antibody response induced by structural proteins from <i>Triatoma virus</i> as potential adjuvants in experimental immunisation models. [PDF]

open access: yesFront Microbiol
Queiroz AMV   +9 more
europepmc   +1 more source

Firearms as a Market‐Driven Epidemic: Potential Pathways to Reduce Preventable Firearm‐Related Harm in the United States

open access: yesThe Milbank Quarterly, EarlyView.
Policy Points For half a century, firearm‐related deaths and injuries have been endemic in the United States, with COVID‐19 contributing to a record high of 48,830 deaths in 2021, an epidemic rate increase. By 2023, national trends masked a significant 10‐fold difference in firearm‐related death rates among states.
ESZTER RIMÁNYI   +8 more
wiley   +1 more source

A systems approach to understanding mechanisms underlying immunisation barriers: a participatory design study in Tanzania. [PDF]

open access: yesBMJ Glob Health
Myemba DT   +6 more
europepmc   +1 more source

Long‐Term Efficacy and Safety of Ligelizumab as Re‐Treatment in Patients With Chronic Spontaneous Urticaria

open access: yesAllergy, EarlyView.
Ligelizumab re‐treatment in CSU patients showed sustained efficacy and tolerability. Over 50% achieved symptom control (UAS7 ≤ 6) by Week 12; benefits maintained through Week 52. No new safety signals observed; aligns with prior PEARL trial outcomes. CSU, chronic spontaneous urticaria; mg, milligram; q4w, every 4 weeks; UAS, urticaria activity score ...
Ana M. Gimenez‐Arnau   +22 more
wiley   +1 more source

HPV vaccine for adolescents in China: what is the next step? [PDF]

open access: yesLancet Reg Health West Pac
The Lancet Regional Health-Western Pacific.
europepmc   +1 more source

International Guideline on the Diagnosis and Management of Pediatric Patients With Hereditary Angioedema

open access: yesAllergy, EarlyView.
ABSTRACT Hereditary angioedema (HAE) with C1 inhibitor deficiency is a rare disease characterized by unpredictable episodes of tissue swelling (angioedema), which, in most cases, occur first under the age of 18 years, and entail a significant burden of disease not only for the patients but also for their families.
Henriette Farkas   +128 more
wiley   +1 more source

Is it a lack of an immunisation workforce or not using the workforce to its potential?

open access: yesAustralian and New Zealand Journal of Public Health
Thomas Aaron Ricks
doaj   +1 more source

Immunisation - to be or not to be?

open access: yesCritical Public Health, 1997
openaire   +1 more source

Home - About - Disclaimer - Privacy